EFSA reveals several areas of concern in novel food applications

novel food

The European Food Safety Authority (EFSA) has found several key areas of concern in novel food submissions it has received for CBD.   Among the areas of primary concern are missing information on applications and data gaps, which would support the evaluation of safety profiles, according to information shared during an EFSA-led webinar on 29 June.  […]

Beyond the CBD list: Frequently asked questions.

A big question mark

The Food Standards Agency (FSA) published a list of permitted CBD products, and their manufacturers, on 31 March 2022. The emergence of the long awaited list has presented more questions to answer. We asked Laura Williamson, Technical Advisor to the Association for the Cannabinoid Industry, to clear up some of the biggest issues.  What led […]

The UK’s CBD list is here. What happens next?

Banner for the CBD list

The long awaited list of ingestible CBD products permitted for sale was published on 31 March 2022. A total of 3,536 products linked to 70 applications have been given the green light to remain on the market by the Food Standards Agency, however the majority are awaiting the outcome of further evidence.   This means making […]

FSA issues clarification and new deadline for toxicology data

A number of CBD companies have until 28 February to provide sufficient toxicology data to the Food Standards Agency, or risk losing the right to sell their products.  Cannabinoid Insight has learnt that up to 40 CBD companies which submitted summary data on epilepsy drug Epidiolex in their novel foods application, have until 28 February […]